线粒体 DNA 质量控制和神经变性-猫眼课题宝

线粒体 DNA 质量控制和神经变性

批准号：

8742026

负责人：

MING GUO

金额：

$30.49万

依托单位：

UNIVERSITY OF CALIFORNIA LOS ANGELES

依托单位国家：

美国

项目类别：

财政年份：

2013

资助国家：

美国

项目状态：

已结题

起止时间：

2013-09-30 至 2017-08-31

来源：

https://reporter.nih.gov/project-details/8742026

关键词：

Adult Affect Age Aged, 80 and over Aging Alzheimer&apos s Disease Animals Autophagocytosis Biological Assay Brain Cell Culture System Cells Cessation of life DNA Damage Defect Disease Disease Progression Drosophila genus Drosophila melanogaster Drug Targeting Engineering Excision FDA approved Free Radicals Functional disorder Genes Genetic Screening Genome Goals Health Human Knowledge Lead Libraries Life Lipid Peroxidation Mammalian Cell Mitochondria Mitochondrial DNA Modeling Molecular Muscle Mutate Mutation Natural History Nerve Degeneration Nervous system structure Neurodegenerative Disorders Neurons Orthologous Gene Oxidative Phosphorylation PINK1 gene Parkinson Disease Pathology Pathway interactions Patients Phenotype Play Population Prevalence Production Proteins Public Health Quality Control Risk Factors Role Staging System Temperature Testing Tissues Work age related fly follow-up genetic analysis genome wide association study genome-wide high throughput screening improved in vivo insight loss of function mitochondrial DNA mutation mitochondrial dysfunction mitochondrial genome mutant parkin gene/protein prevent public health relevance tool

项目摘要

项目成果

MING GUO的其他基金

相似基金

相关文献

中文摘要

翻译

描述（由申请人提供）：神经退行性疾病影响超过50%的80岁以上人群，并且没有治疗可以阻止疾病的进展。大多数（如果不是全部）神经退行性疾病的最强风险因素是衰老。线粒体DNA（mtDNA）突变的积累在人类衰老过程中被观察到，并导致细胞功能障碍和死亡。因此，减少线粒体DNA负荷和改善线粒体DNA质量的策略可能会延缓衰老并减少神经退行性疾病的年龄相关病理。我们已经产生了一个独特的工具，在生活中的黑腹果蝇，含有工程mtDNA突变。我们的目标是利用这些果蝇进行全基因组遗传筛选，以确定那些基因，当突变时，导致抑制或增强线粒体质量控制。

英文摘要

DESCRIPTION (provided by applicant): Neurodegenerative disorders affect more than 50% of the population over the age of 80, and no treatment can halt the progression of the disease. The strongest risk factor for most, if not all, neurodegenerative disorders are aging. Accumulation of mitochondrial DNA (mtDNA) mutations is seen during human aging and leads to cellular dysfunction and death. Thus strategies that reduce the mtDNA load and improve mitochondrial DNA quality are likely to delay aging and reduce the age-related pathologies of neurodegenerative diseases. We have generated a unique tool in living Drosophila melanogaster that contains engineered mtDNA mutations. We aim to use these flies to carry out genome-wide genetic screens to identify those genes, when mutated, lead to suppression or enhancement of the mitochondrial quality control.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文